Quince Therapeutics, Inc. Common Stock (QNCX) is a publicly traded Healthcare sector company. As of September 17, 2026, QNCX trades at $26.79 with a market cap of $29.34M and a P/E ratio of -16.47. QNCX moved +0.00% today. Year to date, QNCX is -95.94%; over the trailing twelve months it is -91.61%. Its 52-week range spans $15.10 to $909.98. Analyst consensus is strong buy with an average price target of $79.60. Rallies surfaces QNCX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
QNCX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. QNCX recently traded at $26.79. Market cap is $29.34M. P/E ratio is -16.47. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $26.79 |
| Market Cap | $29.34M |
| P/E Ratio |
| -16.47 |
| EPS | $-1.68 |
|---|
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $909.98 |
|---|
| 52-Week Low | $15.10 |
|---|
| Volume | 591 |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $0 |
|---|
| Net Income | $-80.77M |
|---|
| Gross Margin | 0.00% |
|---|
5 analysts cover QNCX: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $79.60.